Profund Advisors’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-7,458
| Closed | -$235K | – | 993 |
|
|
2022
Q2 | $235K | Sell |
7,458
-2,923
| -28% | -$106K | 0.01% | 805 |
|
|
2022
Q1 | $457K | Buy |
10,381
+2,050
| +25% | +$88K | 0.02% | 628 |
|
|
2021
Q4 | $362K | Buy |
8,331
+737
| +10% | +$28.9K | 0.01% | 838 |
|
|
2021
Q3 | $238K | Sell |
7,594
-1,506
| -17% | -$59.3K | 0.01% | 1136 |
|
|
2021
Q2 | $385K | Buy |
9,100
+534
| +6% | +$20.8K | 0.01% | 860 |
|
|
2021
Q1 | $322K | Buy |
8,566
+681
| +9% | +$21.3K | 0.01% | 917 |
|
|
2020
Q4 | $213K | Buy |
+7,885
| New | +$203K | 0.01% | 1069 |
|
|
2018
Q4 | – | Sell |
-10,040
| Closed | -$166K | – | 1335 |
|
|
2018
Q3 | $166K | Sell |
10,040
-2,316
| -19% | -$39.4K | 0.01% | 1480 |
|
|
2018
Q2 | $206K | Buy |
12,356
+376
| +3% | +$6.09K | 0.01% | 1396 |
|
|
2018
Q1 | $186K | Buy |
+11,980
| New | +$214K | 0.01% | 1391 |
|
|
2017
Q4 | – | Sell |
-9,385
| Closed | -$274K | – | 1473 |
|
|
2017
Q3 | $274K | Buy |
9,385
+300
| +3% | +$8.86K | 0.01% | 1145 |
|
|
2017
Q2 | $292K | Sell |
9,085
-4,356
| -32% | -$143K | 0.01% | 1106 |
|
|
2017
Q1 | $465K | Sell |
13,441
-1,751
| -12% | -$62.5K | 0.02% | 897 |
|
|
2016
Q4 | $536K | Buy |
15,192
+3,708
| +32% | +$125K | 0.02% | 846 |
|
|
2016
Q3 | $399K | Sell |
11,484
-3,599
| -24% | -$126K | 0.02% | 909 |
|
|
2016
Q2 | $564K | Buy |
15,083
+1,545
| +11% | +$58.1K | 0.03% | 711 |
|
|
2016
Q1 | $547K | Buy |
13,538
+4,884
| +56% | +$182K | 0.03% | 668 |
|
|
2015
Q4 | $311K | Sell |
8,654
-594
| -6% | -$21.5K | 0.01% | 920 |
|
|
2015
Q3 | $295K | Sell |
9,248
-3,055
| -25% | -$104K | 0.02% | 844 |
|
|
2015
Q2 | $418K | Sell |
12,303
-1,544
| -11% | -$52K | 0.02% | 887 |
|
|
2015
Q1 | $469K | Buy |
13,847
+632
| +5% | +$22K | 0.02% | 932 |
|
|
2014
Q4 | $464K | Buy |
13,215
+1,986
| +18% | +$66.9K | 0.02% | 871 |
|
|
2014
Q3 | $368K | Sell |
11,229
-6,873
| -38% | -$234K | 0.02% | 891 |
|
|
2014
Q2 | $615K | Buy |
18,102
+735
| +4% | +$25.2K | 0.03% | 768 |
|
|
2014
Q1 | $608K | Buy |
17,367
+2,158
| +14% | +$76.1K | 0.03% | 765 |
|
|
2013
Q4 | $556K | Buy |
15,209
+137
| +0.9% | +$5.03K | 0.02% | 965 |
|
|
2013
Q3 | $521K | Buy |
15,072
+4,264
| +39% | +$149K | 0.03% | 894 |
|
|
2013
Q2 | $366K | Buy |
+10,808
| New | +$359K | 0.03% | 832 |
|
Other funds holding ACH
Profund Advisors's ACH Position: Q3 2022 in Review
Profund Advisors sold out of Accendra Health (ACH) in Q3 2022, closing a stake of 7,458 shares — an estimated $235K sold.
Profund Advisors first reported a position in ACH in Q2 2013 and held it in 28 quarters. The position peaked at $615K in Q2 2014. 227 funds tracked by Wall St. Rank hold ACH as of Q3 2022.
- Profund Advisors reported no remaining Accendra Health position as of Q3 2022 after selling out during the quarter.
- Profund Advisors sold 7,458 Accendra Health shares in Q3 2022, an estimated $235K.
- Profund Advisors first reported a position in Accendra Health in Q2 2013 and held it in 28 quarters.
- Profund Advisors's Accendra Health position peaked at $615K in Q2 2014.
- 227 funds tracked by Wall St. Rank held Accendra Health as of Q3 2022.
Based on Profund Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.